Calib-og, Merlyn G.

HRN: 24-05-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/04/2025
02/11/2025
IV
1.5g
TID
Infected Breast Mass
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: